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Background: Self-reported atrial fibrillation (AF) and diagnoses from hospital registers are 
often used to identify persons with AF. The objective of this study was to validate self-reported 
AF and hospital discharge diagnoses of AF among participants in a population-based study. 
Materials and methods: Among 50,805 persons who participated in the third survey of the 
HUNT Study (HUNT3), 16,247 participants from three municipalities were included. Individu-
als who reported cardiovascular disease, renal disease, or hypertension in the main question-
naire received a cardiovascular-specific questionnaire. An affirmative answer to a question on 
physician-diagnosed AF in this second questionnaire defined self-reported AF diagnoses in the 
study. In addition, AF diagnoses were retrieved from hospital and primary care (PC) registers. 
All AF diagnoses were verified by review of hospital and PC medical records. 
Results: A total of 502 HUNT3 participants had a diagnosis of AF verified in hospital or PC 
records. Of these, 249 reported their AF diagnosis in the HUNT3 questionnaires and 370 had 
an AF diagnosis in hospital discharge registers before participation in HUNT3. The sensitivity 
of self-reported AF in HUNT3 was 49.6%, specificity 99.2%, positive predictive value (PPV) 
66.2%, and negative predictive value (NPV) 98.4%. The sensitivity of a hospital discharge 
diagnosis of AF was 73.7%, specificity 99.7%, PPV 88.5%, and NPV 99.2%.
Conclusion: Use of questionnaires alone to identify cases of AF has low sensitivity. Extrac-
tion of diagnoses from health care registers enhances the sensitivity substantially and should 
be applied when estimates of incidence and prevalence of AF are studied.
Keywords: atrial fibrillation, epidemiology, diagnosis, questionnaire, validation
Introduction
Atrial fibrillation (AF) affects 2%–3% of the adult population, and has a major impact 
on mortality, morbidity, and quality of life for patients, and cost for the health care 
system.1–3 The prevalence has been increasing over the last few decades, primarily due 
to an aging population. The age-adjusted AF incidence is also rising, probably due to an 
increased prevalence of obesity and other cardiovascular risk factors in the population.4–7
Self-reported AF and diagnoses from hospital registers are the two most common 
sources used in epidemiological studies to identify persons with AF. Validation of these 
approaches has mainly been performed by confirming the AF diagnoses by review of 
electrocardiograms (ECGs), and written documentation in hospital records.8 Few stud-
ies have searched for AF cases missed by these methods and a very few have studied 
primary care (PC) records. To our knowledge, no studies have compared self-reported 
and hospital-diagnosed AF.
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Invited
N=93,860
Participants
N=50,805
Participants from Steinkjer, Verdal, Inderøy
N=16,247
Questionnaire 1
(Q1)
Questionnaire 2
(QCVD)
Self-reported hypertension, or renal or
cardiovascular disease
Has a physician told you that you have AF?
Yes
N=376
Verified AF: 249
No AF: 127
Verified AF: 101b
No AF: 1,045
Verified AF: 87
No AF: 2,533
Verified AF: 65
No AF: 12,040
No dataa
N=1,146
No
N=2,620
Yes
N=4,142
No
N=12,105
Nonparticipants
N=43,055
Figure 1 Flowchart on how the verified diagnoses of AF were found according to answers in the questionnaires.
Notes: a 606 participants did not return the second questionnaire and 540 of those who returned it did not answer the AF question. b 59 had received the second 
questionnaire but not returned it, 42 had returned it but not answered the AF question.
Abbreviations: AF, atrial fibrillation; QCVD, cardiovascular-specific questionnaire.
The primary aim of this study was to validate self-reported 
and hospital-diagnosed AF among participants in a large 
population-based study, and compare those methods using 
diagnoses verified by a systematic review of medical records in 
hospitals and PC centers as a standard. The secondary aim was 
to evaluate the effects of sex, age, and type of AF on the results.
Materials and methods
During 2006–2008, all persons living in the county of Nord-
Trøndelag aged 20 years or older (n=93,860) were invited to the 
third survey of the HUNT Study (HUNT3). Fifty-four percent 
(n=50,805) of those eligible attended.9 We included participants 
living in three municipalities (Steinkjer, Verdal, and Inderøy) 
which have a representative mixture of urban and rural areas, and 
the same medical record software in general practice. Fifty-six 
percent (n=16,247) of the eligible population in the three munici-
palities attended. The study was approved by the regional medical 
ethics research committee, REC Central (Id: 2012/151/REK midt) 
and written informed consent was obtained from all participants.
Questionnaires 
A general questionnaire (Q1) was included in the letter of 
invitation. Attending participants who reported having had 
myocardial infarction, angina pectoris, stroke, renal disease, 
heart failure, hypertension, or other heart diseases were 
given a second questionnaire about cardiovascular diseases 
(cardiovascular-specific questionnaire [QCVD]) which 
included the following question: “Has a doctor told you that 
you have atrial fibrillation?” Of the 16,247 participants from 
the three municipalities, 4,142 received the QCVD and 3,536 
(85.4%) returned it in a prepaid envelope. Among the 3536 
who returned the QCVD, 2,996 (84.7%) answered the AF 
question, 376 responded yes, 2,620 responded no (Figure 1).
Retrieval of AF diagnoses from registers 
in hospitals and PC centers
To identify cases of AF among the 16,247 persons in the three 
study municipalities, their Norwegian personal identification 
numbers were linked to AF diagnoses in registers in hospitals 
and PC centers.
There are two hospitals in the county, in the cities of 
Levanger and Namsos. Norwegian hospital discharge registers 
include dates of admission and discharge for inpatient treat-
ment and day of visit for outpatient treatments. Diagnoses are 
coded as primary or contributory for all visits and have been 
registered electronically since 1988, initially using Interna-
tional Classification of Diseases version 9 (ICD-9) and ver-
sion 10 (ICD-10) from 1999 until present. ICD-9 code 427.3 
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and ICD-10 code I48 were used to identify AF patients. We 
extracted data from 1988 until 12 months after participation 
in HUNT3 from both hospitals in the area. For all participants 
with an AF diagnosis, we extracted clinical information and 
ECG data from the electronic medical records. 
In the three study municipalities, there are 35 general 
practitioners at nine different medical centers. Registers in PC 
centers are administered locally at each center. All visits are 
coded with at least one International Classification of Primary 
Care (ICPC) code. ICPC code K78 “Atrial fibrillation/atrial 
flutter” was used to identify persons with AF. In addition to 
the diagnosis register, each patient has an electronic medical 
record that includes clinical information from each visit at 
the general practitioner. There were no other relevant health 
care providers in the county of Nord-Trøndelag at the study 
time. Relevant health care providers outside the county are 
St Olav’s Hospital and private cardiologists in Trondheim. 
St Olav’s Hospital is situated in the neighboring county, and 
treats more complex patients referred from the local hospitals. 
A medical report for all inpatient and outpatient admissions 
at St Olav’s Hospital and visits to the private cardiologists is 
sent to the local hospital and the patient’s general practitioner 
and thus available for the medical record review conducted.
Persons with either self-reported AF in HUNT3 or a 
diagnosis of AF or atrial flutter in hospital or PC registers 
were included for further validation by review of medical 
records from hospitals and PC centers.
“Verified AF” was defined as an ECG that could be clas-
sified as AF or atrial flutter according to standard criteria.3 
If an ECG was unavailable, the medical record was reviewed 
for a written interpretation. When a physician had described 
the ECG as AF or atrial flutter using standard criteria, the 
case was defined as verified AF. Only participants with 
physician-diagnosed AF before the date of participation in 
HUNT3 were included in this study.
For 17 participants, the information in medical records 
was insufficient for classification. In these cases, two physi-
cians, one specialist in cardiology (JPL) and one specialist in 
internal medicine (HE), evaluated the available information 
separately, grouping them into two categories: “probable AF” 
and “not likely AF”. In case of disagreement, the patient was 
put in the most likely category after a consensus meeting. 
The eleven “probable AF” cases were included as verified 
diagnoses in the study. 
Patients were also classified as having permanent or non-
permanent, ie, paroxysmal or persistent AF.10 For 19 persons, 
the documentation in medical records was insufficient to 
perform a reasonable classification. 
Participants without self-reported AF were considered 
as not having AF if there was no diagnosis of AF either in 
hospitals or in PC centers. To detect possible AF cases not 
included in the registers (false-negative AF), we reviewed 
the hospital and PC records of 500 randomly selected study 
participants without self-reported AF or an AF diagnosis in 
the registers.
Statistics
All participants with a verified diagnosis of AF before par-
ticipation in HUNT3 were included in validation analyses of 
the questionnaires and the hospital discharge diagnoses of 
AF. Participants with a verified diagnosis of AF among those 
who had received the QCVD were included for validation 
of the AF question. The same participants were included in 
subgroup analyses of sex, age, and type of AF. Statistical 
significance testing of contingency tables was performed by 
Fisher’s exact test or c2 with Yates’s correction as appropriate. 
Confidence intervals were calculated using exact confidence 
intervals, computed by the method of Clopper and Pearson.11 
Two-sided P-values with P<0.05 were considered as statisti-
cally significant. Analyses were performed using IBM SPSS 
Statistics 19 and GraphPad Prism 6.
Results
Characteristics of the study population, and the subgroup 
that received QCVD are shown in Table 1. Except a lower 
 proportion of participants on antihypertensive medication, 
Table 1 Baseline characteristics of the three study municipalities 
compared to the general HUNT3 population and those who 
received QCVD
Study All HUNT3 Received
Baseline characteristics participants participants QCVD 
Age at participation, years 52.6±16.1 52.6±16.1 64.4±12.9
Age ≥70 years, n (%) 2,565 (15.8) 8,158 (16.1) 1,515 (36.6)
Height, cm 170.6±9.2 170.5±9.3 169.0±9.3
Weight, kg 79.0±15.1 79.2±15.2 81.7±15.3
Male sex, n (%) 7,406 (45.6) 23,049 (45.4) 2,052 (49.5)
Myocardial infarction, n (%) 517 (3.2) 1,637 (3.2) 515 (12.4)
Antihypertensives, n (%) 3,111 (19.2) 10,608 (20.9) 3,104 (74.9)
Angina pectoris, n (%) 576 (3.6) 1,818 (3.6) 574 (13.9)
Heart failure, n (%) 194 (1.2) 612 (1.2) 193 (4.7)
Stroke, n (%) 431 (2.7) 1,298 (2.6) 426 (10.3)
Renal disease, n (%) 380 (2.3) 1,293 (2.5) 379 (9.2)
Diabetes mellitus, n (%) 688 (4.2) 2,189 (4.3) 451 (10.9)
Current daily smoking, n (%) 2,819 (17.4) 8,585 (16.9) 597 (14.4)
Note: Values are mean ± SD or n (%).
Abbreviations: QCVD, cardiovascular-specific questionnaire; HUNT3, third 
survey of the HUNT Study; SD, standard deviation.
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Table 2 Self-reported vs verified AF diagnoses in all HUNT3 
participants and the subgroup that received QCVD 
 Verified AF diagnosis  
 Yes No Total
Self-reported AFa in all 
participants
Yes 249 127 376
No 253 15,618 15,871
Total 502 15,745 16,247
Self-reported AF in those 
who received QCVD
Yes 249 127 376
No 188 3,578 3,766
Total 437 3,705 4,142
Notes: aSelf reporting of AF was a two step process. The QCVD including the AF 
question was given only to participants  reporting cardiovascular or renal disease in 
the general questionnaire.
Abbreviations: AF, atrial fibrillation; QCVD, cardiovascular-specific questionnaire; 
HUNT3, third survey of the HUNT Study.
Table 3 HUNT3 questionnaires’ ability to identify verified AF diagnoses, compared to hospital-diagnosed AF
Methods of AF identification Sensitivity (95% CI) Specificity (95% CI) PPV (95% CI) NPV (95% CI)
HUNT3 questionnaires – all participants 49.6 (45.1–54.1) 99.2 (99.0–99.3) 66.2 (61.2–71.0) 98.4 (98.2–98.6)
“AF question” – those who received QCVD 57.0 (52.2–61.7) 96.6 (95.9–97.1) 66.2 (61.2–71.0) 95.0 (94.3–95.7)
Hospital discharge diagnoses of AF 73.7 (69.6–77.5) 99.7 (99.6–99.8) 88.5 (85.1–91.4) 99.2 (99.0–99.3)
Abbreviations: AF, atrial fibrillation; CI, confidence interval; NPV, negative predictive value; PPV, positive predictive value; QCVD, cardiovascular-specific questionnaire; 
HUNT3, third survey of the HUNT Study.
the study population was similar to the general HUNT3 
population. Review of hospital and PC records revealed that 
a total of 502 persons among the 16,247 participants had a 
verified diagnosis of AF before they attended the field sta-
tions (Figure 1).
The HUNT3 questionnaires’ ability to 
identify AF
In the study sample of 16,247 participants, 249 out of 376 
persons with self-reported AF (PPV of 66.2%) had informa-
tion in their medical records that confirmed the diagnosis 
(Table 2), but 56 of those did not have a coded AF diagnosis 
in hospital discharge registers. Among the 253 persons who 
did not confirm their verified diagnosis of AF in the question-
naires, 65 had not received the QCVD due to wrong answers 
on inclusion questions, 59 had received the questionnaire 
but did not return it, 42 had returned it without answering 
the AF question, and 87 had answered “no” to the AF ques-
tion (Figure 1). Of the 249 participants that confirmed their 
verified diagnosis of AF in QCVD, 102 answered “no” to 
having “other heart diseases” in the general questionnaire, 
indicating that a large proportion of the participants did not 
consider AF as a heart disease. The sensitivity of finding study 
participants with a verified AF diagnosis with this approach 
was 49.6% (Tables 2 and 3).
In subgroup analyses, the PPV was significantly higher 
and the NPV lower in males than females. The sensitivity, 
specificity, and NPV in this study population were signifi-
cantly lower in persons above 70 years of age than among 
younger persons, while the PPV was higher in those aged 
70 years or older (Table 4). The sensitivity of self-reported 
AF was higher in permanent compared to nonpermanent AF 
(59.4% [95% confidence interval {CI} 52.5–66.1] vs 45.0% 
[95% CI 39.0–51.2], P=0.002). 
The ability of the question “Has a doctor 
told you that you have atrial fibrillation?” 
to identify AF in a high-risk population 
When analyzing only the 4,142 persons who actually received 
the QCVD, the sensitivity of finding study participants with 
a verified AF diagnosis with the question “Has a doctor told 
you that you have atrial fibrillation?” was 57.0% (Tables 2 
and 3). Among the 2,996 persons that actually answered the 
AF question, the sensitivity was 74.1% (95% CI 69.1–78.7), 
specificity 95.2% (95% CI 94.4–96.0), PPV 66.2% (95% CI 
61.2–71.0), and NPV 96.7% (95% CI 95.9–97.3). Of the 127 
persons who answered yes to the AF question, without having 
a verified AF diagnosis, 32 had other supraventricular tachy-
cardia, 21 had palpitations, ten had frequent supraventricular 
or ventricular premature beats, and five had ventricular 
tachycardia. In 59 persons, no information of arrhythmias 
was found in medical records either in hospitals or PC cen-
ters (Table 5). The medical records at St Olav’s Hospital of 
patients with self-reported AF and no AF diagnosis in either 
local hospitals or PC centers were also reviewed, and no more 
AF diagnoses were found.
In subgroup analyses on verified AF in this study popula-
tion, the PPV of self-reported AF was significantly higher 
and the NPV lower in males than in females in those who 
received QCVD. The sensitivity and NPV were significantly 
lower in persons above 70 years of age than those below, 
while the PPV was higher in those aged 70 years or more 
(Table 4).
The ability of hospital discharge diagnoses 
to identify AF
Of the HUNT3 participants from the three study municipali-
ties, 418 had received a diagnosis of AF in hospital discharge 
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Table 4 Validation of self-reported AF and hospital discharge 
diagnoses of AF in subgroups according to sex and age with 
comparisons within subgroups and between self-reported and 
hospital-diagnosed AF
Validation of AF 
diagnosis – subgroups
Sensitivity Specificity PPV NPV
Female sex
HUNT3 questionnaires  
– all participants
44.1f 99.2f 54.1c,f 98.8c,f
“AF question” – those  
who received QCVD
52.0f 96.5f 54.1c,f 96.2c,f
Hospital discharge  
diagnoses of AF
74.6 99.8a 88.0 99.5c
Male sex
HUNT3 questionnaires  
– all participants
52.5f 99.2e 74.3f 97.8f
“AF question” – those  
who received QCVD
59.6f 96.7f 74.3f 93.6f
Hospital discharge  
diagnoses of AF
73.2 99.6 88.8 98.8
Age ≥70 years
HUNT3 questionnaires  
– all participants
44.9b,f 98.1c,d 77.4c,e 92.6c,f
“AF question” – those  
who received QCVD
52.2b,f 96.6f 77.4c,f 90.1c,f
Hospital discharge  
diagnoses of AF
73.1 99.0c 91.4a 96.3c
Age <70 years
HUNT3 questionnaires  
– all participants
57.6f 99.4f 55.8f 99.4e
“AF question” – those  
who received QCVD
65.0 96.6f 55.8f 97.7f
Hospital discharge  
diagnoses of AF
74.7 99.8 84.0 99.7
Notes: aP<0.05, bP<0.01, cP<0.001 for male vs female sex and age over vs under 70 
years. dP<0.05, eP<0.01, fP<0.001 for hospital-diagnosed vs self-reported AF in each 
subgroup.
Abbreviations: AF, atrial fibrillation; NPV, negative predictive value; PPV, positive 
predictive value; QCVD, cardiovascular-specific questionnaire; HUNT3, third 
survey of the HUNT Study.
Table 5 Other arrhythmias and relevant diagnoses in persons 
with self-reported AF, but no verified AF diagnosis
Other arrhythmias/symptoms n
Sinus tachycardia 2
Atrial tachycardia 4
AVRT/WPW syndrome 6
AV-nodal reentry tachycardia 11
Frequent premature supraventricular complexes 8
Frequent premature ventricular complexes 2
Ventricular tachycardia 5
Palpitations 21
Tachycardia, type not specified 9
No arrhythmias 59
Abbreviations: AF, atrial fibrillation; AVRT, atrioventricular reentry tachycardia; 
WPW, Wolff -Parkinson -White.
Table 6 Validation of hospital discharge diagnoses of AF vs 
verified AF diagnoses
Verified AF diagnosis  
Yes No Total
Hospital discharge Yes 370 48 418
diagnosed AF No 132 15,697 15,829
 Total 502 15,745 16,247
Abbreviation: AF, atrial fibrillation.
registers before participating in HUNT3 (Table 6). Of those, 
370 had a diagnosis of AF or atrial flutter that could be 
confirmed by thorough evaluation of their hospital and PC 
medical records, which is 74% of the 502 verified AF diag-
noses. Of the 370 persons with a verified diagnosis of AF, 
177 had not reported AF in HUNT3 questionnaires. When 
including persons with a hospital diagnosis of AF within 3 
and 6 months after the HUNT3 inclusion, three and eight 
more persons were found to have a verified AF diagnosis, 
respectively.
The NPV and specificity of verified hospital discharge 
diagnoses of AF in this study population were significantly 
higher in females than in males, and in those below 70 years 
of age than in those above 70 years (Table 4).
Comparison of the validity of 
questionnaire-based identification and 
hospital discharge diagnoses of AF
When comparing the use of hospital discharge diagnoses of 
AF to identification of AF by the HUNT3 questionnaires, 
hospital discharge diagnoses perform significantly better 
on all parameters in all subgroups, except for the sensitivity 
of finding patients with verified AF under 70 years of age 
(Table 4).
AF that was not detected by 
questionnaires or retrieval of diagnoses 
from registers
After a thorough review of written documentation and ECGs 
in medical records in hospitals and PC centers for 500 random 
participants, we found three persons with a diagnosis of AF 
that was neither self-reported as AF nor registered with an 
AF diagnosis in hospital or PC registers.
Discussion
In this validation study, retrieval of hospital discharge diag-
noses of AF was superior to identification of AF by question-
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naires. Self-reported AF substantially underestimates the true 
sensitivity compared with hospital and PC data. 
The HUNT3 questionnaires’ ability to 
identify AF
In larger epidemiological studies, there is a need to limit 
the number of questions to all participants by creating ques-
tionnaires targeting subgroups. In HUNT3, this was solved 
by handing out a general questionnaire to all participants, 
and further questionnaires only to those with different self-
reported diseases in Q1. There was no specific question on 
AF in Q1, but questions on cardiovascular or renal disease as 
selection to the QCVD. We found poor results of this approach 
for identification of AF, with a study population sensitivity of 
50%, and a PPV of 66%. Including a specific question on AF 
in the general questionnaire could have improved sensitivity. 
Our results also identify the challenge with lower answering 
rates and more incompletely answered forms for follow-up 
questionnaires. Of the participants that did not confirm their 
AF diagnosis in the HUNT3 questionnaires, 40% had received 
QCVD, but either did not return the questionnaire, or returned 
it without answering the AF question.
Validation of the question “Has a doctor 
told you that you have AF?”
When restricting analyses to those having answered the ques-
tion on AF, the study population sensitivity was only 57%, 
and the PPV was also rather low. Many participants seemed 
to have mistaken other arrhythmias and symptoms with AF. 
One should also be aware that these results are obtained in a 
questionnaire that was handed out to participants with self-
reported cardiovascular or renal disease, with a subsequent 
higher prevalence of AF. A total of 87 participants who 
answered “no” to the AF question had actually received a 
diagnosis of AF in hospital or PC before attending HUNT3. 
This underlines the uncertainty in using self-reported AF as 
an endpoint. 
Discharge diagnoses of AF in hospitals
Despite a rather low sensitivity in this study population, AF 
diagnoses retrieved from hospital discharge registries will 
be sufficient for many health-survey studies. There is often a 
delay from registration of AF diagnosis in PC centers to the 
hospital registration. An increased sensitivity will be achieved 
by increasing the time for retrieval by 3 or more months after 
the participation date. However, the medical records should 
then be reviewed to determine whether the first episode of 
AF was before or after the study inclusion date.
Identification of AF cases by 
questionnaires compared to retrieval of 
hospital discharge diagnoses
In this study, a diagnosis of AF in hospital discharge registries 
has a study population sensitivity of 74% and a PPV of 89%, 
which is superior to self-reported AF from questionnaires. 
Reviewing written documentation and ECGs from medical 
records will improve the specificity. However, data from 
hospital-diagnosed AF will underestimate the prevalence 
in the population substantially and  supplementary methods 
should be considered. Nondiagnosed AF and underreporting 
of AF in registries are major limitations to a true estimate of 
AF prevalence. A study using an implantable cardiac moni-
tor  in patients with cryptogenic stroke found that 30% had 
AF after 36 months, compared to 3% of those without an 
implantable cardiac monitor.12 In a 2-week screening study of 
75–76-year-old persons in Sweden, 3% of those were found 
to have previously unknown AF, in addition to the 9.3% hav-
ing known AF.13 This implies that 20%–25% of AF cases in 
the elderly are undiagnosed. The magnitude of undiagnosed 
AF in younger persons has not been studied in detail, but 
three out of 1,296 persons without known cardiac disease, 
hypertension, or diabetes who underwent echocardiography 
in HUNT3 had AF during examination that had not been 
previously diagnosed.14 In addition to undiagnosed AF, there 
is also underreporting of known AF in registries. Out of 
500 random persons without AF in HUNT3 questionnaires 
or hospital and PC diagnosis registries, three persons were 
found to have a verified diagnosis of AF after full review 
of their medical records. The estimate of unrecognized AF 
in such small samples is uncertain, and the magnitude of 
undiagnosed AF in middle-aged persons is unknown. It is 
therefore difficult to estimate this effect precisely, but our 
results clearly overestimate the true sensitivity, and from the 
findings discussed earlier, a 10%–20% overestimation of the 
true sensitivity is possible. However, this should not affect 
the comparisons of the two methods for AF diagnoses in the 
present study, as the persons with a false-negative AF status 
will affect the results of both groups similarly.
Subgroup analyses
There are significant differences regarding study population 
PPV and NPV in subgroups that can be attributed to a lower 
prevalence of AF in females and persons less than 70 years 
of age. A study population sensitivity of self-reported AF 
below 50% in participants over 70 years of age is an important 
finding. As the prevalence of AF increases steeply with older 
age, using self-reported AF will result in a high number of 
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missed AF cases in older populations. The study population 
specificity of self-reported AF is also significantly lower in 
this group than in participants under 70 years of age.
Comparisons to other studies
Although self-reported AF is often used as an endpoint,15–20 
few studies have made attempts to validate this approach. 
The AF diagnosis was validated in a subgroup of 400 per-
sons with self-reported AF in the Physicians’ Health Study. 
Documentation in medical records was missing in ~44% of 
the participants, and the diagnosis of AF was not supported 
in 7%, making the results uncertain. Furthermore, the sen-
sitivity of the question was not reported. The same question 
will probably give considerably poorer results in a general 
population. Psaty et al analyzed the hospital discharge sum-
mary of 10% of their participants with self-reported AF, and 
found no registration of AF in any of those reports.21 Conen 
et al20 reported that 10% of AF patients are asymptomatic, and 
Svennberg et al13 reported that 3.0% of a screened 75/76-year-
old population had undiagnosed AF, limiting the sensitivity 
of self-reported AF.
Multiple studies have estimated the prevalence of AF 
from hospital discharge diagnoses of AF.4,22,23 Jensen et al 
published a review of validated methods for identifying AF 
using administrative data.8 They reported a median sensitivity 
of 79% and a median PPV of 89% in 16 different studies. 
Most of those studies used only inpatient data, and many are 
10–15 years old, with a slightly different prevalence and other 
treatment strategies for AF than today. The study population 
sensitivity in our study is somewhat lower than reported by 
Jensen et al, while the PPV is the same. We have performed 
a more systematic search for AF cases, both in hospitals 
and in PC centers, in addition to using self-reported AF and 
possibly identified more individuals with AF, resulting in a 
lower study population sensitivity for hospital-diagnosed AF. 
Of more recent studies, Norberg et al had a similar 
approach to the present study by including hospital- 
diagnosed, and PC-diagnosed AF.22 In addition, they analyzed 
ECGs from a regional database. They reported a higher 
precision for ICD-10-diagnosed AF than earlier studies, with 
a sensitivity of 93% and a PPV of 96%, explained by using 
AF diagnoses from both hospitals and PC centers to find 
AF cases. In addition, their only false-negative cases were 
persons with an ECG showing AF, but no AF diagnosis in 
the registries. The numbers for hospital discharge diagnoses 
of AF alone were not reported, which are the most relevant 
for other studies, as few regions have easy access to all AF 
diagnoses from PC centers. Even if we included AF diagnoses 
from both hospitals and PC centers, the sensitivity is lower 
in our study as we also included persons with self-reported 
AF. These are persons that might have received the diagnosis 
in other regions of the country  or the diagnosis has been 
forgotten to be coded by physicians. The higher PPV in the 
study by Norberg et al reflects a higher accuracy of coding 
practice, which may be explained by increased awareness of 
AF by both physicians and patients in more recent studies. 
This discrepancy underlines the importance of regional and 
temporal differences in treatment strategies, registration, and 
handling of patients when assessing data from AF registries. 
To our knowledge, no previous studies have validated self-
reported AF and hospital discharge diagnoses of AF in the 
same population.
Strengths and limitations
PC diagnoses of AF have to our knowledge not been vali-
dated previously, and this was also not the aim of this study. 
Including other PC diagnoses like palpitations and other 
supraventricular arrhythmias might have improved the preci-
sion of our estimates, but would have increased the number of 
records needed to review to a large extent, and were therefore 
not included. Restricting the search in PC to ICPC code K78 
possibly results in a slightly higher number of false-negative 
AF cases, and contributes to overestimating especially the 
sensitivity of self-reported and hospital-diagnosed AF.
Compared to the population invited to HUNT3, the par-
ticipants have been shown to have a slightly lower prevalence 
of chronic diseases, including cardiovascular diseases, higher 
socioeconomic status, and a lower mortality than nonpartici-
pants.24 As the difference is minor, this should not affect the 
results of hospital-diagnosed AF to a large extent.
In HUNT3, the AF question is answered only by persons 
with self-reported hypertension or cardiovascular or renal 
disease. This group has a higher prevalence of AF, influencing 
the results. The lower response rate due to two questionnaires 
also has a negative impact. Our results for self-reported AF, 
therefore, cannot be generalized to the normal population 
with an expected lower prevalence of AF and a higher pro-
portion of persons with other arrhythmias.
There are persons with AF, especially among the elderly 
with multiple comorbidities, who are not captured by regis-
ters in hospitals or PC centers. The elderly also have a lower 
sensitivity for self-reported AF. The values for the study 
population sensitivity reported are therefore higher than the 
expected real-life values. An increased knowledge of AF in 
the population and validation of self-reported AF are needed 
to increase the value of self-reported disease. When a scanned 
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ECG was lacking, we had to rely upon written descriptions 
of ECG, which may have caused misclassifications. But after 
reviewing medical records, only 17 participants were left with 
an indefinite diagnosis.
The strengths of this study are the detailed review of 
medical records and diagnoses in both hospitals and PC 
centers, with an available ECG or sufficient written analysis 
of ECG in most cases. We also included self-reported AF, 
and did a thorough review of medical records in a subset of 
persons without information on AF in registries or HUNT3, to 
characterize the ability of the different methods in capturing 
persons with AF. This is, to our knowledge, the first study to 
compare self-reported and hospital-diagnosed AF.
Conclusion
Use of questionnaires alone to define cases of AF has low 
sensitivity and specificity compared with hospital and PC 
data. Hospital discharge diagnoses of AF are acceptable for 
many epidemiological studies and should be preferred. When 
a high level of sensitivity is required, PC registries should 
also be included, but there is still a subset of AF patients that 
are missed and additional approaches should be considered 
to find those. 
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